InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Explore the full record of transactions filed by KELLERMAN DONALD J, Vice-Président, Développement Clinique et Affaires Médicales. Director active across 1 companies, notably Zosano Pharma Corp. Aggregated, 5 disclosures have been recorded. Total volume traded: €3k. The latest transaction was disclosed on 31 March 2022 — Cession. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations5 total
€7604,006 shares@ €0.189825.1% of flow
Common Stock
SEC:0001567619-22-007910:0·
010,000 shares0
Common Stock
SEC:0001567619-21-018474·
010,000 shares0
Common Stock
SEC:0001567619-21-018474:0·
€1,1341,709 shares@ €0.6635100.0% of flow
Common Stock
SEC:0001567619-21-011788·
€1,1341,709 shares@ €0.663537.4% of flow
Common Stock
SEC:0001567619-21-011788:0·
5 of 5 declarations
About KELLERMAN DONALD J
Donald J. Kellerman is the VP, Clinical Dev & Med Affairs at Zosano Pharma Corp. In this role, he oversees the company's clinical development and medical affairs initiatives. His expertise in the pharmaceutical sector is essential in ensuring compliance and effectiveness of development programs.
